Articles From: Keryx Biopharmaceuticals Provides Update From Ongoing Zerenex(TM) (ferric citrate coordination complex) Long-Term Safety Extension Study in Patients With Hyperphosphatemia on Dialysis to Keurig Green Mountain Announces Fiscal 2014 Second Quarter Reporting Date, Conference Call and Live Webcast


2014/2/6
NEW YORK, Feb.
Sign-up for Keryx Biopharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference investment picks
2014/1/7
NEW YORK, Jan.
Sign-up for Keryx Biopharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
2014/1/21
NEW YORK , Jan.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces $90 Million Proposed Public Offering of Common Stock investment picks
2013/10/4
NEW YORK, Oct.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors investment picks
2014/3/12
NEW YORK, March 12, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) , a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease (the "Company"), today announced its financial results for the fourth quarter and year ended December 31, 2013.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results investment picks
2013/7/31
NEW YORK, July 31, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) , a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced its results for the second quarter ended June 30, 2013.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2013 Financial Results investment picks
2013/11/4
NEW YORK, Nov.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results investment picks
2014/3/11
NEW YORK, March 11, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) , a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Thursday, March 13, 2014 at 8:30 a.m. EDT to discuss results for the fourth quarter and year ended December 31, 2013 and a business outlook for 2014.
Sign-up for Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2013 Financial Results investment picks
2013/7/30
NEW YORK, July 30, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) , a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Thursday, August 1, 2013 at 8:30 a.m. EDT to discuss results for the second quarter ended June 30, 2013 and a business outlook for the remainder of 2013.
Sign-up for Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2013 Financial Results investment picks
2014/3/17
NEW YORK, March 17, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that data highlighting the potential pharmacoeconomic benefit of Zerenex™ (ferric citrate coordination complex), the Company's drug candidate for the treatment of hyperphosphatemia in dialysis patients, has been selected for poster presentation during the upcoming Academy of Managed Care Pharmacy's (AMCP) 26 th Annual Meeting and Expo, being held April 1-4, 2014, at the Tampa Convention Center in Tampa, Florida.
Sign-up for Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo investment picks
2014/2/28
Add to Firms' Amplified Social Approach Maximizing Earned Media Reach of Content Across Paid Social, Digital and Search Platforms Globally NEW YORK , Feb.
Sign-up for Ketchum and Zocalo Group Launch Agile Amplification investment picks
2014/3/21
Firm Wins Honorable Mention for Large Agency of the Year NEW YORK , March 21, 2014 /PRNewswire/ -- Ketchum , a leading global public relations firm, and its work on behalf of Gillette was awarded Campaign of the Year at the 15th-annual PRWeek Awards held last night in New York City .
Sign-up for Ketchum Captures PRWeek's 2014 Campaign of the Year Award, Marking Unprecedented Fourth Win investment picks
Firm Will Rebrand as Ketchum SEOUL, South Korea , Sept.
Sign-up for Ketchum Merges With South Korea-Based Firm InComm Brodeur investment picks
2013/11/6
Agency Honored for Fourth Consecutive Year NEW YORK , Nov.
Sign-up for Ketchum Named Top Place to Work in PR by PR News investment picks
Key Hire Brings Experience in Integrated Brand Marketing, Sports Marketing, Marketing to Men NEW YORK , Jan.
Sign-up for Ketchum Sports & Entertainment Adds SVP Eryn McVerry to New York Team investment picks
2013/10/8
Food e-Vangelists Are Informed, Opinionated, and Looking to Impact the Global Food System NEW YORK , Oct.
Sign-up for Ketchum's Global Food 2020 Survey Reveals Powerful New Group of Food Influencers investment picks
2013/12/23
NORWALK, Conn.
Sign-up for Ketel One Sues Arcadia Imports for Trademark Infringement investment picks
2014/3/31
Provides continuity of leadership focus on key growth and system modernization strategies MERRILLVILLE, Ind.
Sign-up for Kettering named CEO of Columbia Pipeline Group investment picks
2014/3/14
By John Kell S&P Dow Jones Indices said Friday it will add Keurig Green Mountain Inc. (GMCR) to its S&P 500 index, one of a handful of index changes announced Friday.
Sign-up for Keurig Green Mountain Added to S&P 500 Index investment picks
2014/3/14
Keurig Green Mountain, Inc. (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas and other beverages with its innovative brewing technology, and Peet’s Coffee & Tea, a premier specialty coffee and tea company, announced a multi-year manufacturing and distribution agreement for Peet’s-branded packs for the Keurig ® brewing system.
Sign-up for Keurig Green Mountain and Peet’s Coffee & Tea Announce Partnership investment picks
2014/3/14
Keurig Green Mountain, Inc. (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas and other beverages with its innovative brewing technology, and Starbucks Coffee Company (NASDAQ: SBUX), the global leader in the premium single cup coffee category, announced today amended terms to the companies’ existing five-year agreement.
Sign-up for Keurig Green Mountain and Starbucks Amend Agreement investment picks
2014/4/8
Keurig Green Mountain, Inc., (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas and other beverages with its innovative brewing technology, today announced that the Company plans to announce financial results for its fiscal 2014 second quarter in a press release to be issued following the close of the financial markets on Wednesday, May 7, 2014.
Sign-up for Keurig Green Mountain Announces Fiscal 2014 Second Quarter Reporting Date, Conference Call and Live Webcast investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Keryx Biopharmaceuticals Provides Update From Ongoing Zerenex(TM) (ferric citrate coordination complex) Long-Term Safety Extension Study in Patients With Hyperphosphatemia on Dialysis to Keurig Green Mountain Announces Fiscal 2014 Second Quarter Reporting Date, Conference Call and Live Webcast
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity